Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_assertion type Assertion NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_head.
- NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_assertion description "[Transgenic mouse studies have indicated that all codon 129 genotypes are susceptible to vCJD and that genotype may influence whether disease appears in a clinical or asymptomatic form, supported by the appearance of the first case of potential asymptomatic vCJD infection in a PRNP 129MV patient.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_provenance.
- NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_assertion evidence source_evidence_literature NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_provenance.
- NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_assertion SIO_000772 25495404 NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_provenance.
- NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_assertion wasDerivedFrom befree-2016 NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_provenance.
- NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_assertion wasGeneratedBy ECO_0000203 NP1246837.RA3zVoNmhSM2kfhukB_Hp-qUXnMMlUF6eNoe6A9OHbHB8130_provenance.